Skip to content

Precigen PGEN Interest Paid

Interest Paid at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$10.4M-20.9%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$1.12M+150%
Arrowhead Research logo
Arrowhead ResearchARWR
$4.75K
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$20.32M-12.7%
Roivant Sciences logo
Roivant SciencesROIV
$0-100%
ALN
Alnylam PharmaceuticalsALNY
$64.2M-6.9%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's interest paid?
Precigen (PGEN) reported interest paid of $2.56M in Q1 2026.
What is the long-term trend for Precigen's interest paid?
Over 4 years (2021 to 2025), Precigen's interest paid has grown at a -16.3% compound annual growth rate (CAGR), from $7.16M to $3.51M.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.